Clinical outcome studies show cost savings and improved patient outcomes with pharmacogenetics in cardiovascular and mental health as well as in other areas including infectious disease, long term care, and adverse drug reactions Cardiovascular Antiplatelet post-MI Notarangelo et al 2018. PMID…